By Nigam Arora & Dr. Natasha Arora
Oversold Bounce
Please click here for a chart of Nasdaq 100 ETF (QQQ).
- The chart shows that coming into today RSI was very oversold.
- When RSI is this oversold, it is a good setup for a bounce.
- Economic data this morning was very negative for the stock market.
- All of the buying today is from the momo crowd.
- In spite of the bounce, smart money is not buying.
- The bounce should be used to properly align the portfolio with current market conditions. Please see the protection bands, cash and hedge levels in today’s Morning Capsule.
- The chart shows Arora signals to take partial profits and not start any new positions just before the decline. Signals don’t get any better than this in real life. These spot on signals follow the Arora signal on February 11th to sell momentum (momo) stocks. February 12th has turned out to be the top in momentum stocks. Since the Arora signal to sell, many momo stocks have lost 40 – 90% of their value.
Markets can generate substantial wealth for knowledgeable investors. NOW YOU TOO CAN ALSO SPECTACULARLY SUCCEED AT MEETING YOUR GOALS WITH THE HELP OF THE ARORA REPORT. You are receiving less than 2% of the content from our paid services. …TO RECEIVE REMAINING 98% INCLUDING MANY ATTRACTIVE INVESTMENT OPPORTUNITIES, TAKE A FREE TRIAL TO PAID SERVICES.
Please click here to take advantage of a FREE 30 day trial.
Nigam Arora
Nigam Arora is known for his accurate stock market calls. Nigam is a distinguished master of the macro. He is a popular columnist with over 100 million page views, an engineer, and nuclear physicist by background. Nigam has founded two Inc. 500 fastest growing companies and has been involved in over 50 entrepreneurial ventures. He is the developer of Theory ZYX of Successful Change Management and is the author of the book on Theory ZYX, as well as the developer of the ZYX Change Method for Investing.
Dr. Natasha Arora
Dr. Natasha Arora has significant expertise in investment analysis especially biotech, healthcare, and technology. Natasha is a graduate of Harvard Medical School followed by a postdoc at MIT. She has published several peer reviewed research papers in top science journals.
